The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

Yesterday the Vaccine Integrity Project (VIP), a panel of leading public health and policy experts, published a viewpoint on ...

It began in 2020 with a coordinated push to generate public backlash to lockdowns. The ultimate aim was restoring normalcy, ending a politically and economically inconvenient crisis. Over time, ...

FDA now requires Pfizer and Moderna COVID-19 vaccines to carry expanded warning labels about risks of myocarditis and pericarditis ...

From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...

The FDA is planning a major shift in COVID-19 vaccine policy limiting future shots to seniors and high-risk groups while calling for more data on younger healthier populations ...

The FDA gave Pfizer and Moderna until May 17 to propose changes to the labels of their COVID-19 vaccines or challenge the ...

The FDA's new vaccine guidelines focus on older adults, citing insufficient evidence for the need for additional COVID shots for those under 65.

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

The US Food and Drug Administration (FDA) is set to sharply restrict vaccine availability to millions of Americans without a ...